Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Senores Pharmaceuticals Ltd.	Q V+ PT	6,474 Small Cap	1,380.60 (-0.74%)	50.69	6.65	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Alivus Life Sciences Ltd.	Q V+ PT	17,570 Small Cap	1,395.40 (-0.37%)	28.52	4.93	6.24	6.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Fredun Pharmaceuticals Ltd.	Q V+ PT	2,195 Small Cap	1,396 (3.60%)	51.69	7.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	3B Blackbio Dx Ltd.	Q V PT	1,139 Small Cap	1,405.55 (-0.15%)	21.76	4.31	27.29	40.23	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Rainbow Childrens Medicare Ltd.	Q V PT	14,770 Small Cap	1,429.45 (-0.76%)	51.26	8.57	21.24	43.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Global Health Ltd.	Q V PT	40,512 Small Cap	1,490.45 (-1.11%)	72.86	9.86	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Concord Biotech Ltd.	Q V PT	15,629 Small Cap	1,544.65 (-2.28%)	60.05	7.98	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Vijaya Diagnostic Centre Ltd.	Q V+ PT	16,042 Small Cap	1,565.10 (0.47%)	85.58	15.93	16.66	14.99	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Onesource Specialty Pharma Ltd.	Q V PT	18,295 Small Cap	1,603.45 (0.21%)	N/A	3.14	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Sai Life Sciences Ltd.	Q V+ PT	34,003 Small Cap	1,604 (-0.24%)	94.41	13.38	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Venus Remedies Ltd.	Q V+ PT	2,125 Small Cap	1,612.10 (1.14%)	18.34	3.1	7.02	18.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Aurobindo Pharma Ltd.	Q V+ PT	99,828 Mid Cap	1,696.10 (-1.23%)	38.11	4.21	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Rubicon Research Ltd.	Q V+ PT	29,031 Small Cap	1,707.05 (-1.40%)	99.43	21.35	41.00	54.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	Poly Medicure Ltd.	Q V PT	17,513 Small Cap	1,713.50 (0.63%)	54.78	5.42	18.98	16.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,40,398 Large Cap	1,847 (-1.12%)	37.05	5.18	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Narayana Hrudayalaya Ltd.	Q V PT	39,437 Mid Cap	1,906 (0.51%)	47.49	8.16	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Dr. Lal Pathlabs Ltd.	Q V PT	31,822 Small Cap	1,918.80 (0.13%)	59.04	12.5	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Novartis India Ltd.	Q V+ PT	5,080 Small Cap	1,997.45 (-0.26%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Ipca Laboratories Ltd.	Q V+ PT	51,020 Mid Cap	2,005 (-0.15%)	40.96	6.1	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Emcure Pharmaceuticals Ltd.	Q V+ PT	38,241 Small Cap	2,005.50 (0.23%)	37.53	7.26	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Laurus Labs Ltd.	Q V+ PT	1,05,645 Mid Cap	2,019 (0.05%)	99.72	19.34	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Lupin Ltd.	Q V PT	98,070 Mid Cap	2,122.95 (0.14%)	17.53	4.07	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	CORONA Remedies Ltd.	Q V+ PT	13,448 Small Cap	2,188 (-1.19%)	68.04	16.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Hester Biosciences Ltd.	Q V PT	1,861 Small Cap	2,190.75 (0.20%)	13.66	4.09	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Wockhardt Ltd.	Q V+ PT	33,911 Small Cap	2,195.75 (0.37%)	86.91	7.06	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Mankind Pharma Ltd.	Q V PT	95,744 Mid Cap	2,463.50 (1.38%)	49.13	5.96	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Glenmark Pharmaceuticals Ltd.	Q V+ PT	67,169 Mid Cap	2,464.20 (0.58%)	38.46	6.31	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	NGL Fine-Chem Ltd.	Q V PT	1,716 Small Cap	2,713.20 (-0.63%)	29.49	4.85	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	RPG Life Sciences Ltd.	Q V+ PT	4,640 Small Cap	2,785.10 (0.65%)	39.74	7.19	42.67	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Caplin Point Laboratories Ltd.	Q V PT	20,887 Small Cap	2,801.50 (1.62%)	31.5	5.71	15.56	20.24	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Together, the businesses will focus on expanding the brand’s footprint into new geographies while gradually strengthening its omnichannel capabilities

Sep, 2026

Fredun Pharmaceuticals informs about press release

Fredun Pharmaceuticals has informed that it enclosed press release titled ‘Fredun Pharmaceuticals Acquires 26% Stake in ?300 Crore-Valued Goodman Vetcare Pvt. Ltd., One of India’s Longest-Standing Dedicated Pet Pharmacies’ issued by the company.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Concord Biotech informs about board meeting

Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, September 23, 2026 to consider the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company. Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Clause 9 of the Code for Prevention of Insider Trading in the securities of the Company, the company has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today i.e. September 19, 2026 till 48 hours after the declaration of outcome of Board Meeting. The trading window shall be opened with effect from September 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Corona Remedies informs about analyst meet

Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Corona Remedies has informed that the officials of the Company will be meeting analysts / investors on Wednesday, September 23, 2026 at 2:00 pm organized by JP Morgan in Ahmedabad. Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is also being made available on the website of the Company at www.coronaremedies.com.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

USFDA completes inspection at Concord Biotech’s formulation facility in Gujarat

The inspection was successfully completed on September 18, 2026 and at the conclusion, the USFDA has issued one minor observation

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Gennex Laboratories Ltd.	250 Crore
2	Take Ltd.	238 Crore
3	Syncom Formulations (India) Ltd.	1,882 Crore
4	Anlon Healthcare Ltd.	1,219 Crore
5	Sigachi Industries Ltd.	1,130 Crore
6	Fischer Medical Ventures Ltd.	2,320 Crore
7	Medico Remedies Ltd.	291 Crore
8	Ambalal Sarabhai Enterprises Ltd.	310 Crore
9	Shukra Pharmaceuticals Ltd.	2,467 Crore
10	Anuh Pharma Ltd.	936 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Fredun Pharmaceuticals acquires 26% stake in Goodman Vetcare

Fredun Pharmaceuticals informs about press release

Glenmark Pharmaceuticals informs about analyst meet

Concord Biotech informs about board meeting

Corona Remedies informs about analyst meet

USFDA completes inspection at Concord Biotech’s formulation facility in Gujarat

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?